Fund review of access & use of Naltrexone for alcohol dependence & chronic pain

Background

We want Government to fund a review into wider access to low-dose Naltrexone for Alcohol Dependence and as a treatment for chronic pain. Studies have shown it’s cost-effective, NICE-approved for alcohol dependency, and it could help reduce NHS strain.

Additional details

We think wider access could help save lives and public money—act now to remove barriers. We think low-dose naltrexone can help manage chronic pain and addiction, offering a safer, non-opioid option. Alcohol and drug misuse cost the UK over £32 billion annually. Drug treatment yields £4–£21 return per £1 spent. Expanding access could save NHS and social care budgets. Fair access is a public health and economic priority.

Where it’s popular

Constituencies with the most signatures on this petition.